MED — MEDIFAST INC
—
NYSE ·
Consumer Staples ·
Food Products ·
CIK 910329 ·
Last close
$12.18
Market Cap
$135.43M
52W High
$13.43
52W Low
$9.22
ADV30
199,064
Next earnings
2026-05-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 76,044,000 | 51,756,000 | -3,295,000 | -2,122,000 | 252,046,000 | 71,529,000 | 54,365,000 |
| Dec 2025 | 75,096,000 | 52,140,000 | -7,803,000 | -18,119,000 | 247,973,000 | 89,303,000 | 49,053,000 |
| Sep 2025 | 89,409,000 | 62,159,000 | -4,081,000 | -2,261,000 | 268,209,000 | 99,526,000 | 53,503,000 |
| Jun 2025 | 105,555,000 | 76,644,000 | -1,066,000 | 2,480,000 | 269,333,000 | 101,694,000 | 53,328,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$3,717,000
Investing CF
$-23,007,000
Financing CF
$-902,000
CapEx
$-5,188,000
Dividends Paid
$-88,000
Buybacks
$-814,000
EPS Diluted TTM
$-1.83
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$156,149,000
Inventory
$21,403,000
Receivables
—
ST Investments
$97,417,000
EBIT TTM
$-16,245,000
Pretax Income TTM
$-8,105,000
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$346,104,000
EBITDA
$-3,985,000
Free Cash Flow
$4,411,250
Enterprise Value
$-29,089,902
Total Cash
$168,946,000
Total Debt
$16,101,000
Shares Out
11,119,115
Trailing EPS
$-1.82
Book Value
$19.28
ROE
-9.8%
ROA
-4.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 385,788,000 | -14,213,000 | -18,672,000 | 247,973,000 | 49,053,000 | — | 6,863,000 |
| Dec 2024 | 602,463,000 | 2,878,000 | 2,091,000 | 284,213,000 | 74,104,000 | — | 24,476,000 |
| Dec 2023 | 1,072,054,000 | 126,402,000 | 99,415,000 | 309,908,000 | 108,427,000 | — | 147,657,000 |
| Dec 2022 | 1,598,577,000 | 184,806,000 | 143,568,000 | 316,213,000 | 161,169,000 | — | 194,570,000 |
TTM Snapshot
Revenues TTM
$168,558,000
NetIncome TTM
$-8,154,000
OpCashFlow TTM
$0
Assets (Latest)
$284,213,000
Forward EPS
$-0.60
Max Pain — expiry 2026-06-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $12.18 · call volume: 1,306 · put volume: 43
Expected Move to 2026-06-18:
±$0.70
(5.75%) —
implied range
$11.48 –
$12.88
· ATM straddle on $12.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BRCC | BRC Inc. | $142.74M | $1.22 | — |
| TAP-A | MOLSON COORS BEVERAGE CO | $115.90M | $45.22 | — |
| ZVIA | Zevia PBC | $103.36M | $1.44 | — |
| ISPR | Ispire Technology Inc. | $101.02M | $1.76 | — |
| BUDA | BUDA JUICE, INC. | $98.51M | $7.84 | — |
News headlines (Yahoo Finance, 1h cache)
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound?
2026-06-03 15:30 · Yahoo
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year?
2026-06-02 13:40 · Yahoo
Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer
2026-05-26 20:05 · Yahoo
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do
2026-05-21 11:00 · Yahoo
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes
2026-05-21 11:00 · Yahoo
Peer-Reviewed Research Is Redefining Weight Loss Program Standards
2026-05-15 17:00 · Yahoo
Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation
2026-05-15 17:00 · Yahoo
3 Highly Ranked Medical Stocks to Buy Now: DVA, GMED, PGNY
2026-05-11 20:45 · Yahoo
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
2026-05-05 17:58 · Yahoo
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care
2026-05-05 15:41 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.